FTC makes final its consent order to approve GlaxoSmithKline merger
When the FTC approved the terms of the consent decree on 18th December 2000 it stated that it would continue investigating the potential effects of the merger in the area of smoking cessation products. The FTC has voted 5-0 to close its investigation into this area.
GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.